Obesity drug cuts cravings and hunger in early trial
NCT ID NCT04779697
First seen Feb 19, 2026 · Last updated May 22, 2026 · Updated 23 times
Summary
This study tested a GLP-1 drug (a type of diabetes medication) in 96 people with obesity but without diabetes. The goal was to see if it reduces cravings, hunger, stress, and weight. Participants received either the drug or a placebo, and researchers measured changes using questionnaires and food intake tests. The results suggest the drug may help control appetite and support weight loss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Yale Stress Center: Yale University
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.